Krupnick J L, Sotsky S M, Simmens S, Moyer J, Elkin I, Watkins J, Pilkonis P A
Department of Psychiatry, Georgetown, University Medical Center, Washington, DC 20007, USA.
J Consult Clin Psychol. 1996 Jun;64(3):532-9. doi: 10.1037//0022-006x.64.3.532.
The relationship between therapeutic alliance and treatment outcome was examined for depressed outpatients who received interpersonal psychotherapy, cognitive-behavior therapy, imipramine with clinical management, or placebo with clinical management. Clinical raters scored videotapes of early, middle, and late therapy sessions for 225 cases (619 sessions). Outcome was assessed from patients' and clinical evaluators' perspectives and from depressive symptomatology. Therapeutic alliance was found to have a significant effect on clinical outcome for both psychotherapies and for active and placebo pharmacotherapy. Ratings of patient contribution to the alliance were significantly related to treatment outcome; ratings of therapist contribution to the alliance and outcome were not significantly linked. These results indicate that the therapeutic alliance is a common factor with significant influence on outcome.
研究了接受人际心理治疗、认知行为治疗、丙咪嗪联合临床管理或安慰剂联合临床管理的门诊抑郁症患者的治疗联盟与治疗结果之间的关系。临床评估人员对225例患者（619次治疗）的早期、中期和晚期治疗录像进行评分。从患者和临床评估人员的角度以及抑郁症状学方面评估治疗结果。结果发现，治疗联盟对心理治疗以及活性药物和安慰剂药物治疗的临床结果均有显著影响。患者对联盟贡献的评分与治疗结果显著相关；治疗师对联盟贡献的评分与结果之间无显著关联。这些结果表明，治疗联盟是对治疗结果有重大影响的共同因素。
